title: Reimbursement Trends and Evidence Requirements for Ultra-Orphan Therapies Across Europe: Optimising Market Access in Increasingly Challenging Markets.
authors.affiliation: Quintiles, Cambridge, MA, USA.
authors.forename: J
authors.initials: J
authors.lastname: Morawski
authors.affiliation: Quintiles Consulting, Durham, NC, USA.
authors.forename: A
authors.initials: A
authors.lastname: Paul
authors.affiliation: Quintiles Global Consulting, Hawthorne, NY, USA.
authors.forename: J F
authors.initials: JF
authors.lastname: Ransom
authors.affiliation: Quintiles, Durham, NC, USA.
authors.forename: D S
authors.initials: DS
authors.lastname: Spinner
authors.affiliation: Quintiles, Hawthorne, NY, USA.
authors.forename: J J
authors.initials: JJ
authors.lastname: Doyle
authors.affiliation: Institute for Pharmacogenomics and Individualized Therapy, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
authors.forename: E C
authors.initials: EC
authors.lastname: Faulkner